Evidence map›Paper›PMID 29156686›Full record

ArticleOncotarget2017

Crosstalk between mismatch repair and base excision repair in human gastric cancer.

Valeria Simonelli, Giuseppe Leuzzi, Giorgia Basile, Mariarosaria D'Errico, Paola Fortini, Annapaola Franchitto, Valentina Viti, Ashley R Brown, Eleonora Parlanti, Barbara Pascucci and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Novel De NovoInternational journal of molecular sciences · 2025
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Two-way crosstalk between BER and c-NHEJ repair pathway is mediated by Pol-β and Ku70.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  8. Article
  9. Functional Interaction BetweenFrontiers in genetics · 2018
    Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Valeria SimonelliDepartment of Environment and Primary Prevention, Istituto Superiore di Sanità, Rome, Italy.
Giuseppe LeuzziDepartment of Environment and Primary Prevention, Istituto Superiore di Sanità, Rome, Italy.
Giorgia BasileDepartment of Environment and Primary Prevention, Istituto Superiore di Sanità, Rome, Italy.
Mariarosaria D'ErricoDepartment of Environment and Primary Prevention, Istituto Superiore di Sanità, Rome, Italy.
Paola FortiniDepartment of Environment and Primary Prevention, Istituto Superiore di Sanità, Rome, Italy.
Annapaola FranchittoDepartment of Environment and Primary Prevention, Istituto Superiore di Sanità, Rome, Italy.
Valentina VitiIstituto di Ricerche Biologia Molecolare P. Angeletti (IRBM), Pomezia (Rome), Italy.
Ashley R BrownUniversity of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA, USA.
Eleonora ParlantiDepartment of Environment and Primary Prevention, Istituto Superiore di Sanità, Rome, Italy.
Barbara PascucciInstitute of Cristallography, Consiglio Nazionale delle Ricerche, Monterotondo Stazione, Rome, Italy.
Domenico PalliMolecular and Nutritional Epidemiology Unit, CSPO, Scientific Institute of Tuscany, Florence, Italy.
Alessandro GiulianiDepartment of Environment and Primary Prevention, Istituto Superiore di Sanità, Rome, Italy.
Fabio PalomboTakis Biotech, Castel Romano, Rome, Italy.
Robert W SobolUniversity of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA, USA.
Eugenia DogliottiDepartment of Environment and Primary Prevention, Istituto Superiore di Sanità, Rome, Italy.
Istituto Superiore di Sanità · ITInstitute of Molecular Biology and Pathology · ITTumour Institute of Tuscany · ITUPMC Hillman Cancer Center · USUSA Mitchell Cancer Institute · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
Novel approaches to enhance tumor cell cytotoxicity of alkylating agentsR01CA148629 · NCI · UNIVERSITY OF SOUTH ALABAMA · PI SOBOL, ROBERT W · 2010 to 2021
$3.4M
NCI NIH HHS P30 CA047904NCI NIH HHS R01 CA148629
6 · The paper itself

Abstract

DNA repair gene expression in a set of gastric cancers suggested an inverse association between the expression of the mismatch repair (MMR) gene MLH1 and that of the base excision repair (BER) gene DNA polymerase β (Polβ). To gain insight into possible crosstalk of these two repair pathways in cancer, we analysed human gastric adenocarcinoma AGS cells over-expressing Polβ or Polβ active site mutants, alone or in combination with MLH1 silencing. Next, we investigated the cellular response to the alkylating agent methyl methanesulfonate (MMS) and the purine analogue 6-thioguanine (6-TG), agents that induce lesions that are substrates for BER and/or MMR. AGS cells over-expressing Polβ were resistant to 6-TG to a similar extent as when MLH1 was inactivated while inhibition of O

Indexed as

alkylation damageDNA polymerase βDNA repairgastric cancermismatch repair

Identifiers

PMID29156686
PMCPMC5689576
OpenAlexW2467389456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.